logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Qingsong Co., Ltd. intends to use 30 million to 45 million yuan to repurchase company shares.

date
10/06/2026
announced that it plans to repurchase company shares using 30 to 45 million RMB, with a repurchase price not exceeding 10 RMB per share.
Latest
now
Kangda New Materials: Abnormal Stock Trading Activity Indicates Multiple Operational Risks
1 m ago
Shell executives: Iran conflict causes oil supply gap, the world is currently overdrawn on future production capacity.
1 m ago
Chinese High Speed Transmission (00658.HK) Achieves Profit and Expects an Annual Net Profit of Not Less Than 680 Million Yuan for 2025, Turning Losses into Profits Compared to the Previous Year.
2 m ago
Hanssen Pharmaceuticals (03692): The application for the market approval of HS-10568 injection has been accepted by the National Medical Products Administration.
2 m ago
Weitian Medical-B (02235.HK) spent 220,600 Hong Kong dollars to repurchase 30,000 shares on June 10th.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.